Patachi, B., Jensen, K. H., Gothelf, A., Bernsdorf, M., Friborg, J., & Kristensen, C. A. (2025). Pembrolizumab as first-line treatment for recurrent and metastatic head and neck cancer – real-world single-centre data. Acta Oncologica, 64, 143–146. https://doi.org/10.2340/1651-226X.2025.42128